BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 12803333)

  • 1. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract.
    Fukuda N; Shinohara H; Sakabe K; Nada T; Tamura Y
    J Heart Valve Dis; 2003 May; 12(3):333-40. PubMed ID: 12803333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between plasma B-type natriuretic peptide levels and left ventricular diastolic function using color kinetic imaging.
    Harada M; Hara F; Yamazaki J
    J Cardiol; 2010 Jul; 56(1):91-6. PubMed ID: 20447804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between brain natriuretic peptide and coronary stenosis: influence of aging].
    Suzuki N; Mori H; Hazama M; Takahashi K; Moriya M; Yano K
    J Cardiol; 2004 Mar; 43(3):117-22. PubMed ID: 15067799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in left ventricular function in patients with isolated aortic stenosis.
    Favero L; Giordan M; Tarantini G; Ramondo AB; Cardaioli P; Isabella G; Chioin R; Lupia M; Razzolini R
    J Heart Valve Dis; 2003 May; 12(3):313-8. PubMed ID: 12803330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hemoglobin concentration and creatinine clearance in pro-B-type natriuretic peptide-based left ventricular filling pressure prediction in patients with preserved left ventricular systolic function.
    Choi EY; Ha JW; Joung B; Ko YG; Choi D; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Am J Cardiol; 2008 Feb; 101(3):364-9. PubMed ID: 18237601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased plasma brain natriuretic peptide levels after a successful maze procedure.
    Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M
    J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study.
    Bergler-Klein J; Mundigler G; Pibarot P; Burwash IG; Dumesnil JG; Blais C; Fuchs C; Mohty D; Beanlands RS; Hachicha Z; Walter-Publig N; Rader F; Baumgartner H
    Circulation; 2007 Jun; 115(22):2848-55. PubMed ID: 17515464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels.
    Oosterhof T; Tulevski II; Vliegen HW; Spijkerboer AM; Mulder BJ
    Am J Cardiol; 2006 Apr; 97(7):1051-5. PubMed ID: 16563914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy.
    Alter P; Rupp H; Rominger MB; Vollrath A; Czerny F; Klose KJ; Maisch B
    Can J Physiol Pharmacol; 2007 Aug; 85(8):790-9. PubMed ID: 17901889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
    Nguyen TH; Neil CJ; Sverdlov AL; Mahadavan G; Chirkov YY; Kucia AM; Stansborough J; Beltrame JF; Selvanayagam JB; Zeitz CJ; Struthers AD; Frenneaux MP; Horowitz JD
    Am J Cardiol; 2011 Nov; 108(9):1316-21. PubMed ID: 21871590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of left ventricular filling pattern on exercise-induced changes of natriuretic peptides in patients with suspected coronary artery disease.
    Møller JE; Bergeron S; Jaffe A; Pellikka PA
    Int J Cardiol; 2008 Feb; 124(2):204-10. PubMed ID: 17442418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
    Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
    Murakami Y; Shimada T; Inoue S; Shimizu H; Ohta Y; Katoh H; Nakamura K; Ishibashi Y
    Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure.
    Lancellotti P; Cosyns B; Piérard LA
    Europace; 2008 Apr; 10(4):496-501. PubMed ID: 18319268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.